Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
TAE Life Sciences
AddedFeb 15, 2024
UpdatedJun 18, 2026
TAE Life Sciences

TAE Life Sciences

Series B

Biotech firm innovating radiation therapy for accessible, advanced cancer treatment.

HQ
Irvine, CA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Founded in Irvine, CA, TAE Life Sciences is a biotechnology firm dedicated to transforming cancer treatment through advanced radiation therapy. Their core mission is to make Boron Neutron Capture Therapy (BNCT) accessible and convenient for clinical use, offering a promising solution for previously untreatable cancers. The company focuses on developing the Alphabeamâ„¢ Neutron System and precision pharmacology to deliver boron drugs safely and effectively.

TAE Life Sciences has garnered attention from notable investors and industry experts, contributing to its rapid development. Though their devices and drugs are still in development and not yet available for commercial use, the company has made significant strides in the field of targeted radiotherapy. Their innovative approach holds the potential to revolutionize cancer care, providing safer and more effective treatment options for patients worldwide.

TAE Life Sciences - Similar Companies

TAE Technologies logo

TAE Technologies

tae.com

3T Biosciences logo

3T Biosciences

3tbiosciences.com

Taiga Biotechnologies logo

Taiga Biotechnologies

LifeBridge Innovations logo

LifeBridge Innovations

Tau Therapeutics logo

Tau Therapeutics

A2 Biotherapeutics logo

A2 Biotherapeutics

a2bio.com

Tavotek Biotherapeutics logo

Tavotek Biotherapeutics

tavotek.com

MonarchBio logo

MonarchBio

monarch-bio.com

Artbio logo

Artbio

artbio.com

TNeuroPharma logo

TNeuroPharma

tneuropharma.com

Tactiva Therapeutics logo

Tactiva Therapeutics

Therapyx logo

Therapyx

therapyxinc.com

Telo Therapeutics logo

Telo Therapeutics

NantBio logo

NantBio

LinaTech logo

LinaTech

TAE Life Sciences - Quick Facts

Who are TAE Life Sciences' competitors?

Companies similar to TAE Life Sciences include TAE Technologies, 3T Biosciences, Taiga Biotechnologies and LifeBridge Innovations.

When was TAE Life Sciences founded?

TAE Life Sciences was founded in 2017.

Where is TAE Life Sciences' headquarters located?

TAE Life Sciences' headquarters is located in Irvine, CA, US.

When was TAE Life Sciences' last funding round?

TAE Life Sciences' most recent funding round was for $30M (USD) in June 2020.

How much has TAE Life Sciences raised to-date?

As of Jun 2, 2020, TAE Life Sciences has raised a total of $70M (USD).

How many employees does TAE Life Sciences have?

TAE Life Sciences has 77 employees as of Feb 4, 2024.

TAE Life Sciences - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Software
Customer
  • Enterprise
Main Product
  • Radiation Therapy
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 5 more industry codes
NAICS
  • 622000Hospitals
  • 622100General Medical and Surgical Hospitals
  • 622110General Medical and Surgical Hospitals
  • 623000Nursing and Residential Care Facilities
SIC
  • 8060Hospitals